Neptune Wellness Solutions(GB:0V8K)
GB:0V8K
Neptune Wellness Solutions financials statements
Neptune Wellness Solutions (0V8K) Ratios
0 Followers
Neptune Wellness Solutions Ratios
GB:0V8K's free cash flow for Q3 2024 was C$-3.03M. For the 2024 fiscal year, GB:0V8K's free cash flow was increased by C$703.00 and operating cash flow was C$-2.96M. See a summary of the company’s cash flow.
| Ratios | Jun 22 | Jun 21 | Mar 20 | Mar 19 | Mar 18 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.23 | 3.68 | 2.25 | 1.23 | 3.29 |
| Quick Ratio | 0.67 | 2.97 | 1.73 | 0.98 | 2.84 |
| Cash Ratio | 0.29 | 2.46 | 0.96 | 0.49 | 2.31 |
| Solvency Ratio | -1.56 | -1.72 | -1.48 | -0.71 | 1.35 |
| Operating Cash Flow Ratio | -1.79 | -2.31 | -1.97 | -0.42 | -0.72 |
| Short-Term Operating Cash Flow Coverage | -84.69 | -244.86 | -10.60 | -2.41 | -1.77 |
| Net Current Asset Value | C$ -6.73M | C$ 41.30M | C$ 9.59M | C$ 2.55M | C$ 20.06M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.14 | 0.08 | 0.03 | 0.04 | 0.05 |
| Debt-to-Equity Ratio | 0.30 | 0.12 | 0.03 | 0.05 | 0.05 |
| Debt-to-Capital Ratio | 0.23 | 0.11 | 0.03 | 0.05 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.19 | 0.09 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.18 | 1.61 | 1.18 | 1.31 | 1.14 |
| Debt Service Coverage Ratio | -35.20 | -39.53 | -9.75 | -3.74 | 1.59 |
| Interest Coverage Ratio | -57.48 | -55.70 | -187.65 | -36.79 | 0.40 |
| Debt to Market Cap | 13.23 | 2.54 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 5271.50 | 6582.52 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.07 | 0.53 | 0.35 | 0.44 | -2.26 |
| Profitability Margins | |||||
| Gross Profit Margin | -15.44% | -77.33% | -6.22% | 31.15% | 22.88% |
| EBIT Margin | -169.86% | -358.26% | -188.24% | -92.33% | 32.68% |
| EBITDA Margin | -157.39% | -304.41% | -159.90% | -79.82% | 45.50% |
| Operating Profit Margin | -181.42% | -369.70% | -523.78% | -93.34% | 4.23% |
| Pretax Profit Margin | -173.01% | -360.85% | -190.22% | -94.19% | 27.85% |
| Net Profit Margin | -153.64% | -347.93% | -205.77% | -94.88% | 63.41% |
| Continuous Operations Profit Margin | -173.01% | -351.03% | -205.77% | -94.88% | 33.78% |
| Net Income Per EBT | 88.80% | 96.42% | 108.18% | 100.74% | 227.70% |
| EBT Per EBIT | 95.36% | 97.61% | 36.32% | 100.91% | 657.64% |
| Return on Assets (ROA) | -71.43% | -52.47% | -25.59% | -19.21% | 13.76% |
| Return on Equity (ROE) | -155.82% | -84.30% | -30.07% | -25.13% | 15.68% |
| Return on Capital Employed (ROCE) | -118.61% | -64.10% | -72.53% | -24.27% | 1.04% |
| Return on Invested Capital (ROIC) | -116.61% | -62.18% | -70.83% | -23.13% | 0.98% |
| Return on Tangible Assets | -122.64% | -72.40% | -42.90% | -20.77% | 14.77% |
| Earnings Yield | -8073.46% | -2158.89% | 0.00% | 0.00% | 0.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.42 | 3.25 | 1.94 | 3.15 | 3.80 |
| Payables Turnover | 2.74 | 4.11 | 19.88 | 15.65 | 8.85 |
| Inventory Turnover | 3.30 | 2.89 | 2.45 | 2.50 | 3.14 |
| Fixed Asset Turnover | 2.06 | 0.70 | 0.34 | 0.39 | 0.51 |
| Asset Turnover | 0.46 | 0.15 | 0.12 | 0.20 | 0.22 |
| Working Capital Turnover Ratio | 1.35 | 0.70 | 1.58 | 1.14 | 0.84 |
| Cash Conversion Cycle | 34.39 | 149.99 | 318.22 | 238.90 | 171.22 |
| Days of Sales Outstanding | 56.84 | 112.32 | 187.71 | 116.01 | 96.07 |
| Days of Inventory Outstanding | 110.53 | 126.49 | 148.87 | 146.21 | 116.39 |
| Days of Payables Outstanding | 132.99 | 88.83 | 18.36 | 23.33 | 41.25 |
| Operating Cycle | 167.38 | 238.82 | 336.58 | 262.23 | 212.47 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -18025.25 | -22744.68 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Per Share | -18811.84 | -25576.66 | 0.00 | 0.00 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | -22.92 | -8.03 | -2.22 | -0.90 | -1.63 |
| Capital Expenditure Coverage Ratio | -22.92 | -8.03 | -2.22 | -0.90 | -1.63 |
| Operating Cash Flow Coverage Ratio | -3.79 | -3.90 | -7.09 | -2.41 | -1.77 |
| Operating Cash Flow to Sales Ratio | -1.11 | -2.00 | -1.61 | -0.46 | -0.39 |
| Free Cash Flow Yield | -6107.74% | -1394.58% | 0.00% | 0.00% | 0.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.01 | -0.05 | 0.00 | 0.00 | 0.00 |
| Price-to-Sales (P/S) Ratio | 0.02 | 0.16 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.02 | 0.04 | 0.00 | 0.00 | 0.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.02 | -0.07 | 0.00 | 0.00 | 0.00 |
| Price-to-Operating Cash Flow Ratio | -0.02 | -0.08 | 0.00 | 0.00 | 0.00 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Enterprise Value Multiple | -0.09 | 0.48 | 0.35 | 0.44 | -2.26 |
| Enterprise Value | 6.56M | -40.84M | -8.29M | -4.76M | -17.05M |
| EV to EBITDA | -0.09 | 0.48 | 0.35 | 0.44 | -2.26 |
| EV to Sales | 0.13 | -1.45 | -0.56 | -0.35 | -1.03 |
| EV to Free Cash Flow | -0.12 | 0.65 | 0.24 | 0.36 | 1.65 |
| EV to Operating Cash Flow | -0.12 | 0.73 | 0.35 | 0.76 | 2.66 |
| Tangible Book Value Per Share | 5643.21 | 35228.29 | 0.00 | 0.00 | 0.00 |
| Shareholders’ Equity Per Share | 15958.71 | 46967.87 | 0.00 | 0.00 | 0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.03 | -0.08 | -0.01 | -0.21 |
| Revenue Per Share | 16184.78 | 11379.74 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -24866.25 | -39594.06 | 0.00 | 0.00 | 0.00 |
| Tax Burden | 0.89 | 0.96 | 1.08 | 1.01 | 2.28 |
| Interest Burden | 1.02 | 1.01 | 1.01 | 1.02 | 0.85 |
| Research & Development to Revenue | 0.02 | 0.05 | 0.10 | 0.30 | 0.49 |
| SG&A to Revenue | 0.00 | 3.17 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.16 | 0.35 | 0.79 | 0.00 | 0.00 |
| Income Quality | 0.72 | 1.19 | 0.52 | 0.35 | -0.47 |
Currency in CAD

